U.S. pharma huge copyright scrapped two experimental weight loss pills previous year—a the moment-daily pill, lotiglipron, on account of elevated liver enzymes and also a 2 times-daily pill, danuglipron, because of powerful side effects—but CEO Albert Bourla has said the company is determined to “play and win” within the being overweight sp